ATE206050T1 - Okulares hypotensium - Google Patents
Okulares hypotensiumInfo
- Publication number
- ATE206050T1 ATE206050T1 AT95912428T AT95912428T ATE206050T1 AT E206050 T1 ATE206050 T1 AT E206050T1 AT 95912428 T AT95912428 T AT 95912428T AT 95912428 T AT95912428 T AT 95912428T AT E206050 T1 ATE206050 T1 AT E206050T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- alkyl
- formula
- alkenyl
- carboxyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4540494 | 1994-03-16 | ||
PCT/JP1995/000444 WO1995024902A1 (fr) | 1994-03-16 | 1995-03-16 | Reducteur de tension oculaire |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE206050T1 true ATE206050T1 (de) | 2001-10-15 |
Family
ID=12718322
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01102527T ATE266402T1 (de) | 1994-03-16 | 1995-03-16 | Okulares hypotonikum |
AT95912428T ATE206050T1 (de) | 1994-03-16 | 1995-03-16 | Okulares hypotensium |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01102527T ATE266402T1 (de) | 1994-03-16 | 1995-03-16 | Okulares hypotonikum |
Country Status (20)
Country | Link |
---|---|
US (1) | US5925664A (de) |
EP (2) | EP1110551B1 (de) |
KR (1) | KR100211446B1 (de) |
CN (2) | CN1104898C (de) |
AT (2) | ATE266402T1 (de) |
AU (1) | AU684916B2 (de) |
CZ (1) | CZ284395B6 (de) |
DE (2) | DE69533045T2 (de) |
DK (2) | DK1110551T3 (de) |
ES (2) | ES2221872T3 (de) |
FI (2) | FI114897B (de) |
GR (1) | GR3036989T3 (de) |
HK (1) | HK1000551A1 (de) |
HU (1) | HUT74734A (de) |
MX (1) | MX9604109A (de) |
NO (1) | NO311068B1 (de) |
NZ (1) | NZ282485A (de) |
PT (2) | PT1110551E (de) |
RU (1) | RU2123847C1 (de) |
WO (1) | WO1995024902A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1198650C (zh) * | 1999-06-11 | 2005-04-27 | 三共株式会社 | 局部给药用眼压降低组合物 |
JP4000505B2 (ja) * | 1999-12-01 | 2007-10-31 | 第一三共株式会社 | 緑内障を治療するための併用剤 |
GR20000100281A (el) * | 2000-08-17 | 2002-05-24 | Ιωαννης Ματσουκας | Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων |
AU2002218527A1 (en) * | 2000-12-05 | 2002-06-18 | Sankyo Company Limited | Ocular tension-lowering compositions for topical administration |
BRPI0409293A (pt) * | 2003-04-15 | 2006-04-11 | Sankyo Co | medicamento para a prevenção ou tratamento de doenças angiogênicas intraoculares |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6323868A (ja) * | 1986-07-11 | 1988-02-01 | イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー | アンギオテンシン2受容体遮断性イミダゾ−ル |
US5138069A (en) * | 1986-07-11 | 1992-08-11 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking imidazoles |
CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
US4820843A (en) * | 1987-05-22 | 1989-04-11 | E. I. Du Pont De Nemours And Company | Tetrazole intermediates to antihypertensive compounds |
CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
RU2099330C1 (ru) * | 1989-06-30 | 1997-12-20 | Е.И.Дюпон Де Немур Энд Компани | Замещенные имидазолы или их фармацевтически приемлемые соли и фармацевтическая композиция |
WO1991015206A1 (en) * | 1990-04-05 | 1991-10-17 | E.I. Du Pont De Nemours And Company | Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists |
US5196444A (en) * | 1990-04-27 | 1993-03-23 | Takeda Chemical Industries, Ltd. | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
US5126342A (en) * | 1990-10-01 | 1992-06-30 | Merck & Co., Inc. | Imidazole angiotensin ii antagonists incorporating acidic functional groups |
FI112942B3 (fi) * | 1991-02-21 | 2012-03-13 | Daiichi Sankyo Co Ltd | Menetelmä kohonneen verenpaineen hoitoon ja ennaltaehkäisyyn käyttökelpoisten 4'-(1H-imidatsol-1-yylimetyyli)-1,1' -bifenyylijohdannaisten valmistamiseksi |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
US5219856A (en) * | 1992-04-06 | 1993-06-15 | E. I. Du Pont De Nemours And Company | Angiotensin-II receptor blocking, heterocycle substituted imidazoles |
DK0573218T3 (da) * | 1992-06-02 | 2001-06-18 | Sankyo Co | 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse |
US5310929A (en) * | 1992-08-06 | 1994-05-10 | E. I. Du Pont De Nemours And Company | Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists |
CZ283315B6 (cs) * | 1992-12-17 | 1998-02-18 | Sankyo Company Limited | Bifenylové deriváty, způsob výroby a farmaceutické prostředky k léčení hypertense a srdečních onemocnění, které tyto deriváty obsahují |
CZ154994A3 (en) * | 1993-07-02 | 1995-09-13 | Senju Pharma Co | Visual hypotensive agent |
AU1423795A (en) * | 1994-02-08 | 1995-08-29 | Novartis Ag | Treatment of normotensive glaucoma with angiotensin ii antagonists |
-
1995
- 1995-03-16 HU HU9602534A patent/HUT74734A/hu unknown
- 1995-03-16 DK DK01102527T patent/DK1110551T3/da active
- 1995-03-16 AT AT01102527T patent/ATE266402T1/de not_active IP Right Cessation
- 1995-03-16 PT PT01102527T patent/PT1110551E/pt unknown
- 1995-03-16 NZ NZ282485A patent/NZ282485A/en not_active IP Right Cessation
- 1995-03-16 AU AU19602/95A patent/AU684916B2/en not_active Ceased
- 1995-03-16 DE DE69533045T patent/DE69533045T2/de not_active Expired - Fee Related
- 1995-03-16 DE DE69522955T patent/DE69522955T2/de not_active Expired - Fee Related
- 1995-03-16 EP EP01102527A patent/EP1110551B1/de not_active Expired - Lifetime
- 1995-03-16 AT AT95912428T patent/ATE206050T1/de not_active IP Right Cessation
- 1995-03-16 MX MX9604109A patent/MX9604109A/es not_active IP Right Cessation
- 1995-03-16 WO PCT/JP1995/000444 patent/WO1995024902A1/ja active IP Right Grant
- 1995-03-16 KR KR1019960705082A patent/KR100211446B1/ko not_active IP Right Cessation
- 1995-03-16 CZ CZ962694A patent/CZ284395B6/cs not_active IP Right Cessation
- 1995-03-16 RU RU96121253A patent/RU2123847C1/ru active
- 1995-03-16 CN CN95193132A patent/CN1104898C/zh not_active Expired - Fee Related
- 1995-03-16 EP EP95912428A patent/EP0795326B1/de not_active Expired - Lifetime
- 1995-03-16 ES ES01102527T patent/ES2221872T3/es not_active Expired - Lifetime
- 1995-03-16 DK DK95912428T patent/DK0795326T3/da active
- 1995-03-16 ES ES95912428T patent/ES2163501T3/es not_active Expired - Lifetime
- 1995-03-16 PT PT95912428T patent/PT795326E/pt unknown
-
1996
- 1996-09-13 NO NO19963854A patent/NO311068B1/no not_active IP Right Cessation
- 1996-09-16 FI FI963645A patent/FI114897B/fi active IP Right Grant
- 1996-09-16 US US08/725,197 patent/US5925664A/en not_active Expired - Fee Related
-
1997
- 1997-10-23 HK HK97102015A patent/HK1000551A1/xx not_active IP Right Cessation
-
2001
- 2001-10-24 GR GR20010401862T patent/GR3036989T3/el not_active IP Right Cessation
-
2002
- 2002-05-11 CN CNB021199396A patent/CN1202819C/zh not_active Expired - Fee Related
-
2004
- 2004-09-24 FI FI20041236A patent/FI115197B/fi active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE194335T1 (de) | 4,5-diaryloxazol-derivate | |
DK0449216T3 (da) | 3,5-Di-tertiærbutyl-4-hydroxyphenylmethylenderivater af 2-substituerede thiazolidinoner, oxazolidinoner og imidazolidinoner som antiinflammatoriske midler | |
DE69331843D1 (de) | Xanthine-Derivate als Antidepressiva | |
DE69111816D1 (de) | Indolederivate und ihre verwendung als serotonin-antagoniste. | |
DE69717091D1 (de) | Oxazole derivate,ihre herstellung und verwendung | |
ATE252074T1 (de) | Phenylalkylcarbonsäure-derivate | |
ATE421524T1 (de) | 5-ring-heterocyclen, ihre herstellung, ihre verwendung als inhibitoren der leukozytenadhäsion und sie enthaltende pharmazeutische präparate | |
ATE206050T1 (de) | Okulares hypotensium | |
DK147588D0 (da) | Benzoxazinderivat samt fremgangsmaade til fremstilling deraf | |
DE69226931D1 (de) | Guanidinothiazolederivate und ihre Anwendung als H2-Rezeptor-Antagonisten | |
FI872997A0 (fi) | Amidderivat. | |
NO893039D0 (no) | Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler. | |
EP0878475A3 (de) | 5-(4-Piperidinyl)dibenzothiazepine derivate und 5-(4-piperidinyl)dibenzoxazepinderivate, und antiarrhythmische Mittel | |
DE68905222D1 (de) | 7-(1-imidazolyl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropylchinolincarbonsaeure-derivate, ihre herstellung und ihre verwendung als arzneimittel. | |
TH18321B (th) | สารออกฤทธิ์ต้านตัวรับแทคิไคนินชนิดนอนเพปไทด์ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |